COVID-19 时代在一家三级保健学术医院的头颈部癌症的诊断和治疗延误：我们应该预期什么？
Diagnosis and treatment delay of head and neck cancers during COVID-19 era in a tertiary care academic hospital: what should we expect?
机构信息
Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno, Italy.
Department of Surgical Sciences, University of Turin, Turin, Italy.
出版信息
Eur Arch Otorhinolaryngol. 2022 Feb;279(2):961-965. doi: 10.1007/s00405-021-06834-1. Epub 2021 Apr 30.
BACKGROUND
Since the spreading of SARS-CoV-2 from China, all deferrable medical activities have been suspended, to redirect resources for the management of COVID patients. The goal of this retrospective study was to investigate the impact of COVID-19 on head and neck cancers' diagnosis in our Academic Hospital.
METHODS
A retrospective analysis of patients treated for head and neck cancers between March 12 and November 1, 2020 was carried out, and we compared these data with the diagnoses of the same periods of the 5 previous years.
RESULTS
47 patients were included in this study. We observed a significative reduction in comparison with the same period of the previous 5 years.
CONCLUSIONS
Our findings suggest that the COVID-19 pandemic is associated with a decrease in the number of new H&N cancers diagnoses, and a substantial diagnostic delay can be attributable to COVID-19 control measures.
背景
自 SARS-CoV-2 在中国传播以来，所有可延迟的医疗活动都已暂停，以重新调配资源用于 COVID 患者的管理。本回顾性研究的目的是调查 COVID-19 对我院头颈部癌症诊断的影响。
方法
对 2020 年 3 月 12 日至 11 月 1 日期间治疗的头颈部癌症患者进行回顾性分析，并将这些数据与前 5 年同期的诊断结果进行比较。
结果
本研究共纳入 47 例患者，与前 5 年同期相比，显著减少。
结论
我们的研究结果表明，COVID-19 大流行与新诊断的 H&N 癌症数量减少有关，COVID-19 控制措施可导致大量诊断延迟。
Zotero 插件